{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:03:13Z","timestamp":1787166193713,"version":"build-2736575974"},"reference-count":30,"publisher":"Pharmaceutical Society of Japan","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b16-01025","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T18:15:52Z","timestamp":1496254552000},"page":"844-851","source":"Crossref","is-referenced-by-count":17,"title":["Histone Deacetylase Inhibitors Sensitize Murine B16F10 Melanoma Cells to Carbon Ion Irradiation by Inducing G1 Phase Arrest"],"prefix":"10.1248","volume":"40","author":[{"given":"Katsuyo","family":"Saito","sequence":"first","affiliation":[{"name":"Department of Quantum Biology, Graduate School of Medicine, Gunma University"},{"name":"Laboratory of Tumor Biology, Faculty of Pharmacy, Takasaki University of Health and Welfare"},{"name":"Department of Radiation-Applied Biology, Takasaki Advanced Radiation Research Institute (TARRI), Quantum Beam Science Research Directorate (QuBS), National Institutes for Quantum and Radiological Science and Technology (QST)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Funayama","sequence":"additional","affiliation":[{"name":"Department of Quantum Biology, Graduate School of Medicine, Gunma University"},{"name":"Department of Radiation-Applied Biology, Takasaki Advanced Radiation Research Institute (TARRI), Quantum Beam Science Research Directorate (QuBS), National Institutes for Quantum and Radiological Science and Technology (QST)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Radiation-Applied Biology, Takasaki Advanced Radiation Research Institute (TARRI), Quantum Beam Science Research Directorate (QuBS), National Institutes for Quantum and Radiological Science and Technology (QST)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Murakami","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Biology, Faculty of Pharmacy, Takasaki University of Health and Welfare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Quantum Biology, Graduate School of Medicine, Gunma University"},{"name":"Department of Radiation-Applied Biology, Takasaki Advanced Radiation Research Institute (TARRI), Quantum Beam Science Research Directorate (QuBS), National Institutes for Quantum and Radiological Science and Technology (QST)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Schadendorf D, Fisher DE, Garbe C, Gershenwald JE, Grob JJ, Halpern A, Herlyn M, Marchetti MA, McArthur G, Ribas A, Roesch A, Hauschild A. Melanoma. <i>Nat. Rev. Dis. Primers<\/i>, <b>1<\/b>, 15003 (2015).","DOI":"10.1038\/nrdp.2015.55"},{"key":"2","unstructured":"2) Fort M, Guet S, Husheng S, Calitchi E, Belkacemi Y, On behalf of AROME (Association of Radiotherapy &amp; Oncology of the Mediterranean arEa) and TRONE (Transatlantic Radiation Oncology NEtwork). Role of radiation therapy in melanomas: Systematic review and best practice in 2016. <i>Crit. Rev. Oncol. Hematol.<\/i>, <b>99<\/b>, 362\u2013375 (2016)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. <i>Nat. Rev. Drug Discov.<\/i>, <b>13<\/b>, 673\u2013691 (2014).","DOI":"10.1038\/nrd4360"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Murakami T, Sato A, Chun NA, Hara M, Naito Y, Kobayashi Y, Kano Y, Ohtsuki M, Furukawa Y, Kobayashi E. Transcriptional modulation using HDACi depsipeptide promotes immune cell-mediated tumor destruction of murine B16 melanoma. <i>J. Invest. Dermatol.<\/i>, <b>128<\/b>, 1506\u20131516 (2008).","DOI":"10.1038\/sj.jid.5701216"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fukuda T, Wu W, Okada M, Maeda I, Kojima Y, Hayami R, Miyoshi Y, Tsugawa K, Ohta T. Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage. <i>Cancer Sci.<\/i>, <b>106<\/b>, 1050\u20131056 (2015).","DOI":"10.1111\/cas.12717"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kawano T, Akiyama M, Agawa-Ohta M, Mikami-Terao Y, Iwase S, Yanagisawa T, Ida H, Agata N, Yamada H. Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation. <i>Int. J. Oncol.<\/i>, <b>37<\/b>, 787\u2013795 (2010).","DOI":"10.3892\/ijo_00000728"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL, Ismail S, Stevens C, Meyn RE. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. <i>Clin. Cancer Res.<\/i>, <b>11<\/b>, 4912\u20134922 (2005).","DOI":"10.1158\/1078-0432.CCR-04-2088"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Blattmann C, Oertel S, Thiemann M, Dittmar A, Roth E, Kulozik AE, Ehemann V, Weichert W, Huber PE, Stenzinger A, Debus J. Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy. <i>Radiat. Oncol.<\/i>, <b>10<\/b>, 146 (2015).","DOI":"10.1186\/s13014-015-0455-z"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Barazzuol L, Jeynes JC, Merchant MJ, W\u00e9ra AC, Barry MA, Kirkby KJ, Suzuki M. Radiosensitization of glioblastoma cells using a histone deacetylase inhibitor (SAHA) comparing carbon ions with X-rays. <i>Int. J. Radiat. Biol.<\/i>, <b>91<\/b>, 90\u201398 (2015).","DOI":"10.3109\/09553002.2014.946111"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yokota Y, Hase Y, Shikazono N, Tanaka A, Inoue M. LET dependence of lethality of carbon ion irradiation to single tobacco cells. <i>Int. J. Radiat. Biol.<\/i>, <b>79<\/b>, 681\u2013685 (2003).","DOI":"10.1080\/09553000310001622832"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kiefer J. Deposition of radiation energy. <i>Biological radiation effects<\/i>. Springer-Verlag, Heidelberg, pp. 55\u201387 (1990).","DOI":"10.1007\/978-3-642-83769-2_4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kazantsev AG, Thompson LM. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. <i>Nat. Rev. Drug Discov.<\/i>, <b>7<\/b>, 854\u2013868 (2008).","DOI":"10.1038\/nrd2681"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ll\u00e8res D, James J, Swift S, Norman DG, Lamond AI. Quantitative analysis of chromatin compaction in living cells using FLIM-FRET. <i>J. Cell Biol.<\/i>, <b>187<\/b>, 481\u2013496 (2009).","DOI":"10.1083\/jcb.200907029"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) T\u00f3th KF, Knoch TA, Wachsmuth M, Frank-St\u00f6hr M, St\u00f6hr M, Bacher CP, M\u00fcller G, Rippe K. Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. <i>J. Cell Sci.<\/i>, <b>117<\/b>, 4277\u20134287 (2004).","DOI":"10.1242\/jcs.01293"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Vidali G, Gershey EL, Allfrey VG. Chemical studies of histone acetylation. The distribution of \u03b5-<i>N<\/i>-acetyllysine in calf thymus histones. <i>J. Biol. Chem.<\/i>, <b>243<\/b>, 6361\u20136366 (1968).","DOI":"10.1016\/S0021-9258(18)93148-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Takata H, Hanafusa T, Mori T, Shimura M, Iida Y, Ishikawa K, Yoshikawa K, Yoshikawa Y, Maeshima K. Chromatin compaction protects genomic DNA from radiation damage. <i>PLOS ONE<\/i>, <b>8<\/b>, e75622 (2013).","DOI":"10.1371\/journal.pone.0075622"},{"key":"17","unstructured":"17) Kamada T, Tsujii H, Blakely EA, Debus J, De Neve W, Durante M, J\u00e4kel O, Mayer R, Orecchia R, P\u00f6tter R, Vatnitsky S, Chu WT. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. <i>Lancet Oncol.<\/i>, <b>16<\/b>, e93\u2013e100 (2015)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Goodhead DT. Mechanisms for the biological effectiveness of high-LET radiations. <i>J. Radiat. Res.<\/i>, <b>40<\/b> (Suppl.), S1\u2013S13 (1999).","DOI":"10.1269\/jrr.40.S1"},{"key":"19","unstructured":"19) Ghorai A, Bhattacharyya NP, Sarma A, Ghosh U. Radiosensitivity and induction of apoptosis by high LET carbon ion beam and low LET gamma radiation: A comparative study. <i>Scientifica<\/i>, <b>2014<\/b>, 438030 (2014)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Takahashi A, Kubo M, Ma H, Nakagawa A, Yoshida Y, Isono M, Kanai T, Ohno T, Furusawa Y, Funayama T, Kobayashi Y, Nakano T. Nonhomologous end-joining repair plays a more important role than homologous recombination repair in defining radiosensitivity after exposure to high-LET radiation. <i>Radiat. Res.<\/i>, <b>182<\/b>, 338\u2013344 (2014).","DOI":"10.1667\/RR13782.1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zhao X, Yang W, Shi C, Ma W, Liu J, Wang Y, Jiang G. The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells. <i>Tumour Biol.<\/i>, <b>32<\/b>, 335\u2013346 (2011).","DOI":"10.1007\/s13277-010-0126-5"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Li GC, Zhang X, Pan TJ, Chen Z, Ye ZQ. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21<sup>WAF1<\/sup> and G<sub>1<\/sub> cell cycle arrest. <i>Int. J. Urol.<\/i>, <b>13<\/b>, 581\u2013586 (2006).","DOI":"10.1111\/j.1442-2042.2006.01344.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kim YB, Ki SW, Yoshida M, Horinouchi S. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. <i>J. Antibiot.<\/i>, <b>53<\/b>, 1191\u20131200 (2000).","DOI":"10.7164\/antibiotics.53.1191"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Richon VM, Sandhoff TW, Rifkind RA, Marks PA. Histone deacetylase inhibitor selectively induces p21<sup>WAF1<\/sup> expression and gene-associated histone acetylation. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>97<\/b>, 10014\u201310019 (2000).","DOI":"10.1073\/pnas.180316197"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Koprinarova M, Botev P, Russev G. Histone deacetylase inhibitor sodium butyrate enhances cellular radiosensitivity by inhibiting both DNA nonhomologous end joining and homologous recombination. <i>DNA Repair<\/i>, <b>10<\/b>, 970\u2013977 (2011).","DOI":"10.1016\/j.dnarep.2011.07.003"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. <i>Nat. Rev. Drug Discov.<\/i>, <b>5<\/b>, 769\u2013784 (2006).","DOI":"10.1038\/nrd2133"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Zhang Y, Jung M, Dritschilo A, Jung M. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. <i>Radiat. Res.<\/i>, <b>161<\/b>, 667\u2013674 (2004).","DOI":"10.1667\/RR3192"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Kawano T, Akiyama M, Agawa-Ohta M, Mikami-Terao Y, Iwase S, Yanagisawa T, Ida H, Agata N, Yamada H. Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation. <i>Int. J. Oncol.<\/i>, <b>37<\/b>, 787\u2013795 (2010).","DOI":"10.3892\/ijo_00000728"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Huang L, Sowa Y, Sakai T, Pardee AB. Activation of the p21<sup>WAF1\/CIP1<\/sup> promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. <i>Oncogene<\/i>, <b>19<\/b>, 5712\u20135719 (2000).","DOI":"10.1038\/sj.onc.1203963"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Nomura H, Sakai T. Histone deacetylase inhibitor activates the WAF1\/Cip1 gene promoter through the Sp1 sites. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>241<\/b>, 142\u2013150 (1997).","DOI":"10.1006\/bbrc.1997.7786"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/6\/40_b16-01025\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T20:55:14Z","timestamp":1659041714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/6\/40_b16-01025\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-01025","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}